We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Northwest Natural Holding Company | NYSE:NWN | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 39.44 | 9 | 11:31:31 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported)
August 9, 2024
(Exact name of registrant as specified in its charter)
Commission File No.
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
(Address of principal executive offices) (Zip Code)
Registrant’s Telephone Number, including area code:
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
Trading |
Name of each exchange | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01 | Other Events. |
On August 9, 2024, Northwest Natural Holding Company (the “Company”) filed with the U.S. Securities and Exchange Commission (“SEC”) a Registration Statement on Form S-3 (No. 333-281437) (the “New Registration Statement”), which became effective upon filing. The New Registration Statement replaced the Company’s Registration Statement on Form S-3 (No. 333-258792) (the “Prior Registration Statement”), which was scheduled to expire on August 13, 2024. The Prior Registration Statement was deemed terminated upon the effectiveness of the New Registration Statement on August 9, 2024.
On August 9, 2024, in connection with the filing of the New Registration Statement, the Company filed a prospectus supplement (the “ATM Prospectus Supplement”) relating to the offering of the Company’s common stock, no par value (the “Common Stock”) with an aggregate offering price of up to $200,000,000, through the Company’s at the market equity distribution program pursuant to the Equity Distribution Agreement, dated August 13, 2021, between the Company and Wells Fargo Securities, LLC, J.P. Morgan Securities LLC, and RBC Capital Markets, LLC (each, an “Agent”) (as supplemented by the Joinder Letter, dated August 9, 2024 (the “Joinder Letter”), with BMO Capital Markets Corp., also an Agent, and the Written Notice delivered August 9, 2024, relating to, among other things, an increase in the maximum gross sales price for shares of Common Stock that may be offered under the Equity Distribution Agreement, the “Equity Distribution Agreement”). The offering of the Common Stock will be made pursuant to the New Registration Statement, a base prospectus dated August 9, 2024, and the ATM Prospectus Supplement. The Company has no obligation to offer or sell any Common Stock under the Equity Distribution Agreement and may at any time suspend offers under the Equity Distribution Agreement.
Sales of shares of Common Stock under the Equity Distribution Agreement, if any, may be made (i) by any method or payment permitted by law to be an “at the market offering” as defined in Rule 415 under the Securities Act of 1933, as amended, including without limitation sales made directly on the New York Stock Exchange, the existing trading market for the Common Stock, or to or through a market maker or through an electronic communications network, including block transactions, at market prices prevailing at the time of sale or at prices relating to such prevailing market prices or (ii) any other method permitted by law, including but not limited to privately negotiated transactions (if, and only if, the Company, the applicable Agents and other relevant parties have so agreed in writing). Any shares of Common Stock offered under the Equity Distribution Agreement will be offered pursuant to the New Registration Statement.
The foregoing description of the Equity Distribution Agreement does not purport to be complete and is qualified in its entirety by reference to the Equity Distribution Agreement, which was filed as Exhibit 1.1 to the Current Report on Form 8-K filed with the SEC on August 13, 2021.
In connection with the issuance and sale of the shares of Common Stock, the Company is also filing legal opinions regarding the validity of the shares of Common Stock as Exhibits 5(a) and 5(b) for the purpose of incorporating the opinions into the New Registration Statement.
Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits
See exhibit index below.
EXHIBIT INDEX
Exhibit | Description | |
5(a) | Opinion of MardiLyn Saathoff, Esquire, regarding the validity of the securities. | |
5(b) | Opinion of Morgan, Lewis & Bockius LLP, regarding the validity of the securities. | |
23(a) | The consent of MardiLyn Saathoff, Esquire is included in her opinion filed as Exhibit 5(a). | |
23(b) | The consent of Morgan, Lewis & Bockius LLP is included in its opinion filed as Exhibit 5(b). | |
104 | Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
NORTHWEST NATURAL HOLDING COMPANY | ||||||
(Registrant) | ||||||
Dated: August 9, 2024 | /s/ Shawn M. Filippi | |||||
Vice President, Chief Compliance Officer and Corporate Secretary |
Exhibit 5(a)
August 9, 2024
Northwest Natural Holding Company
250 SW Taylor Street
Portland, Oregon 97204
Ladies and Gentlemen:
With respect to the Registration Statement No. 333-281437 (the Registration Statement) filed with the Securities and Exchange Commission (the Commission) on August 9, 2024, by Northwest Natural Holding Company (the Company), relating to the offer and sale of up to $200,000,000 of the Companys common stock, no par value (the Shares) as described in the Companys Prospectus dated August 9, 2024 and Prospectus Supplement dated August 9, 2024, and pursuant to the Equity Distribution Agreement, dated August 13, 2021, between the Company and Wells Fargo Securities, LLC, J.P. Morgan Securities LLC and RBC Capital Markets, LLC (as supplemented by the Joinder Letter, dated August 9, 2024, with BMO Capital Markets Corp., and the Written Notice delivered August 9, 2024, relating to, among other things, an increase in the maximum gross sales price for Shares that may be offered under such Equity Distribution Agreement, the Equity Distribution Agreement), I have reviewed such documents and records as I have deemed necessary to enable me to express an opinion on the matters covered hereby. As to questions of fact material to the opinions expressed herein, I have relied upon representations and certifications of the officers of the Company and appropriate public officials without independent verification of such matters except. In such examination, I have assumed the genuineness of all signatures, the legal capacity of all natural persons other than the Company, the authenticity of the documents submitted to me as originals, the conformity with the originals of all documents submitted to me as originals of the documents submitted to me as certified, facsimile or electronic copies and the authenticity of the originals of all documents submitted to me as copies.
Based upon the foregoing, I am of the opinion that:
1. | The Company is a corporation duly organized and validly existing under the laws of the State of Oregon. |
2. | The Shares to be issued and sold by the Company pursuant to the Equity Distribution Agreement, when issued and delivered by the Company in accordance with the Equity Distribution Agreement against payment of the consideration contemplated thereby, will be duly authorized, validly issued, fully paid and non-assessable. |
This opinion is limited to the laws of the State of Oregon. As to all matters of the laws of the State of Oregon, Morgan, Lewis & Bockius LLP is authorized to rely on this opinion as if it were addressed to them.
I hereby consent to the use of this opinion as an exhibit to the Current Report on Form 8-K to be filed by the Company on or about August 9, 2024, which will be incorporated by reference in the Registration Statement, and to the reference to me under the caption Legality in the prospectus included in the Registration Statement.
In giving the foregoing consent, I do not thereby admit that I come within the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended, or the rules and regulations promulgated by the Commission thereunder.
Very truly yours, |
/s/ MardiLyn Saathoff |
MardiLyn Saathoff, Esq. |
Senior Vice President, Regulation and General Counsel |
2
Exhibit 5(b)
August 9, 2024
Northwest Natural Holding Company
250 SW Taylor Street
Portland, Oregon 97204
Ladies and Gentlemen:
With respect to the Registration Statement No. 333-281437 (the Registration Statement) filed with the Securities and Exchange Commission (the Commission) on August 9, 2024, by Northwest Natural Holding Company (the Company), relating to the offer and sale of up to $200,000,000 of the Companys common stock, no par value (the Shares) as described in the Companys Prospectus dated August 9, 2024 and Prospectus Supplement dated August 9, 2024, and pursuant to the Equity Distribution Agreement, dated August 13, 2021, between the Company and Wells Fargo Securities, LLC, J.P. Morgan Securities LLC and RBC Capital Markets, LLC (as supplemented by the Joinder Letter, dated August 9, 2024, with BMO Capital Markets Corp., and the Written Notice delivered August 9, 2024, relating to, among other things, an increase in the maximum gross sales price for Shares that may be offered under such Equity Distribution Agreement, the Equity Distribution Agreement), we have reviewed such documents and records as we have deemed necessary to enable us to express an opinion on the matters covered hereby. As to questions of fact material to the opinions expressed herein, we have relied upon representations and certifications of the officers of the Company and appropriate public officials without independent verification of such matters. In such examination, we have assumed the genuineness of all signatures, the legal capacity of all natural persons, the authenticity of the documents submitted to us as originals, the conformity with the originals of all documents submitted to us as originals of the documents submitted to us as certified, facsimile or electronic copies and the authenticity of the originals of all documents submitted to us as copies.
Based upon the foregoing, we are of the opinion that:
1. | The Company is a corporation duly organized and validly existing under the laws of the State of Oregon. |
2. | The Shares to be issued and sold by the Company pursuant to the Equity Distribution Agreement, when issued and delivered by the Company in accordance with the Equity Distribution Agreement against payment of the consideration contemplated thereby, will be duly authorized, validly issued, fully paid and non-assessable. |
Morgan, Lewis & Bockius LLP | ||||
101 Park Avenue | ||||
New York, NY 10178-0060 | +1.212.309.6000 | |||
United States | +1.212.309.6001 |
This opinion is limited to the laws of the State of Oregon and the federal laws of the United States. As to all matters of the laws of the State of Oregon, we have relied upon an opinion of even date herewith addressed to you by MardiLyn Saathoff, Esq.
We hereby consent to the use of this opinion as an exhibit to the Current Report on Form 8-K to be filed by the Company on or about August 9, 2024, which will be incorporated by reference in the Registration Statement, and to the reference to me under the caption Legality in the prospectus included in the Registration Statement. In giving the foregoing consent, we do not thereby admit that we belong to the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended, or the rules and regulations promulgated by the Commission thereunder.
Very truly yours, |
/s/ Morgan, Lewis and Bockius LLP |
2
Document and Entity Information |
Aug. 09, 2024 |
---|---|
Cover [Abstract] | |
Entity Registrant Name | Northwest Natural Holding Co |
Amendment Flag | false |
Entity Central Index Key | 0001733998 |
Document Type | 8-K |
Document Period End Date | Aug. 09, 2024 |
Entity File Number | 1-38681 |
Entity Incorporation State Country Code | OR |
Entity Tax Identification Number | 82-4710680 |
Entity Address, Address Line One | 250 SW Taylor Street |
Entity Address, City or Town | Portland |
Entity Address, State or Province | OR |
Entity Address, Postal Zip Code | 97204 |
City Area Code | (503) |
Local Phone Number | 226-4211 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Security 12b Title | Common Stock |
Trading Symbol | NWN |
Security Exchange Name | NYSE |
Entity Emerging Growth Company | false |
1 Year Northwest Natural Chart |
1 Month Northwest Natural Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions